Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 29:12:906695.
doi: 10.3389/fonc.2022.906695. eCollection 2022.

A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess

Affiliations
Review

A Narrative Review of Preventive Central Lymph Node Dissection in Patients With Papillary Thyroid Cancer - A Necessity or an Excess

David D Dolidze et al. Front Oncol. .

Abstract

Objective: This review article summarises the latest evidence for preventive central lymph node dissection in patients with papillary thyroid cancer taking into account the possible complications and risk of recurrence.

Background: Papillary thyroid cancer is the most frequent histological variant of malignant neoplasms of the thyroid gland. It accounts for about 80-85% of all cases of thyroid cancer. Despite good postoperative results and an excellent survival rate in comparison with many other malignant diseases, tumor metastases to the cervical lymph nodes are frequent. Most researchers agree that the presence of obvious metastases in the lymph nodes requires careful lymph node dissection. It was suggested to perform preventive routine lymphadenectomy in all patients with malignant thyroid diseases referred to surgery.

Methods: It was performed the literature review using the "papillary thyroid cancer", "central lymph node dissection", "hypocalcemia", "recurrent laryngeal nerve paresis", "metastasis", "cancer recurrence" along with the MESH terms. The reference list of the articles was carefully reviewed as a potential source of information. The search was based on Medline, Scopus, Google Scholar, eLibrary engines. Selected publications were analyzed and their synthesis was used to write the review and analyse the role of preventive central lymph node dissection in patients with papillary thyroid cancer.

Conclusions: The necessity of preventive central lymph node dissection in patients with differentiated papillary thyroid carcinoma is still controversial. There is much evidence that it increases the frequency of transient hypocalcemia. Due to the fact that this complication is temporary, its significance in clinical practice is debatable. It can also be assumed that an extant of surgery in the neck area is associated with an increased risk of recurrent laryngeal nerve injury. However, most studies indicate that this injury is associated more with thyroidectomy itself than with lymph node dissection. Recurrent laryngeal nerve dysfunction is also a temporary complication in the vast majority of cases. At the same time, a large amount of data shows that central lymph node dissection reduces the risk of thyroid cancer recurrence in two times.

Keywords: cancer recurrence; hypocalcemia; metastasis; papillary thyroid cancer; preventive central lymph node dissection; recurrent laryngeal nerve paresis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the review.
Figure 2
Figure 2
Groups of cervical lymph nodes. I – below the body of the lower jaw; IA: group of chin nodes; IB: group of submandibular lymph nodes; II: upper jugular; IIA: upper jugular anterior; IIB: upper jugular posterior; III: middle jugular; IV: lower jugular; V: posterior (lateral) triangle of the neck; VA: accessory; VB: supraclavicular; VI: anterior space of the neck.

References

    1. Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients. World J Surg (2018) 42(3):615–22. doi: 10.1007/s00268-018-4479-z - DOI - PMC - PubMed
    1. Mazzaferri EL, Jhiang SM. Long-Term Impact of Initial Surgical and Medical Therapy on Papillary and Follicular Thyroid Cancer. Am J Med (1994) 97(5):418–28. doi: 10.1016/0002-9343(94)90321-2 - DOI - PubMed
    1. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically Significant Prognostic Factors for Differentiated Thyroid Carcinoma: A Population-Based, Nested Case-Control Study. Cancer (2006) 106(3):524–31. doi: 10.1002/cncr.21653 - DOI - PubMed
    1. Davies L, Welch HG. Thyroid Cancer Survival in the United States: Observational Data From 1973 to 2005. Arch Otolaryngol Head Neck Surg (2010) 136(5):440–4. doi: 10.1001/archoto.2010.55 - DOI - PubMed
    1. Liu L-S, Liang J, Li J-H, Liu X, Jiang L, Long J-X, et al. . The Incidence and Risk Factors for Central Lymph Node Metastasis in Cn0 Papillary Thyroid Microcarcinoma: A Meta-Analysis. Eur Arch Oto Rhino Laryngol (2017) 274(3):1327–38. doi: 10.1007/s00405-016-4302-0 - DOI - PubMed

LinkOut - more resources